Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor.
Belzacq-Casagrande AS, Bachelot F, De Oliveira C, Coutadeur S, Maurier-Mahé F, Throo E, Chauvignac C, Pognante L, Petibon A, Taverne T, Beausoleil E, Leblond B, Pando MP, Désiré L.
Belzacq-Casagrande AS, et al. Among authors: pando mp.
Invest New Drugs. 2013 Apr;31(2):304-19. doi: 10.1007/s10637-012-9858-y. Epub 2012 Aug 10.
Invest New Drugs. 2013.
PMID: 22878926